|
MRPL37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49260000004148E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.44600000001805E-06 |
| Normal-vs-Stage2 |
1.184140E-03 |
| Normal-vs-Stage3 |
2.880500E-02 |
| Normal-vs-Stage4 |
8.687800E-01 |
| Stage1-vs-Stage2 |
4.866400E-01 |
| Stage1-vs-Stage3 |
5.788000E-01 |
| Stage1-vs-Stage4 |
1.695010E-01 |
| Stage2-vs-Stage3 |
3.656800E-01 |
| Stage2-vs-Stage4 |
1.143020E-01 |
| Stage3-vs-Stage4 |
1.809240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54064999999814E-05 |
| Normal-vs-AfricanAmerican |
3.14150000002567E-06 |
| Normal-vs-Asian |
6.226400E-01 |
| Caucasian-vs-AfricanAmerican |
4.167000E-01 |
| Caucasian-vs-Asian |
8.009000E-01 |
| AfricanAmerican-vs-Asian |
6.936800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.6230000005345E-07 |
| Normal-vs-Female |
7.460300E-03 |
| Male-vs-Female |
3.527500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.764200E-02 |
| Normal-vs-Extreme_Weight |
1.34410000018903E-07 |
| Normal-vs-Obese |
2.42369999999825E-05 |
| Normal-vs-Extreme_Obese |
6.246400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.703700E-02 |
| Normal_Weight-vs-Obese |
1.759200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.584400E-01 |
| Extreme_Weight-vs-Obese |
6.385600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.321200E-01 |
| Obese-vs-Extreme_Obese |
4.153400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.160600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.05140000000925E-06 |
| Normal-vs-Age(61-80Yrs) |
1.50810999999251E-05 |
| Normal-vs-Age(81-100Yrs) |
9.788300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.283400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.717000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.865000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.184000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.308000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.025000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.42280000003936E-08 |
| Normal-VS-Type2 PRCC |
1.160430E-01 |
| Normal-VS-KIRP CIMP |
3.008400E-01 |
| Normal-VS-Unclassified PRCC |
4.798500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.562900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.588830E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.934200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.980400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.705800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.957200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.138600E-03 |
| Normal-vs-N1 |
4.182800E-01 |
| Normal-vs-N2 |
4.353400E-01 |
| N0-vs-N1 |
3.798400E-01 |
| N0-vs-N2 |
5.463700E-02 |
| N1-vs-N2 |
2.568800E-01 |
|
|
